C#CCN(C(=O)C(F)(F)F)C(/C=C\C(=O)OC)(C(=O)OCC)C(=O)OCC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?